September 2026
The US direct-to-consumer laboratory testing market size was evaluated at USD 1.34 billion in 2026 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 9.03%.
September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The global arbovirus testing market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
September 2026
The global drug of abuse testing market size was estimated at USD 15.42 billion in 2026 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
September 2026
The sustainable laboratory plasticware market was valued at USD 970.97 million in 2026, with leading companies including Merck KGaA, Sartorius AG, DWK Life Sciences.
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
July 2025
The global GI stool testing market size is estimated to hit around USD 5.02 billion by 2034 increasing from USD 2.93 billion in 2024, with a CAGR of 5.53%.
June 2025
The packaging testing market size was estimated at USD 13.32 billion in 2024 and is predicted to be worth around USD 33.27 billion by 2034, at a CAGR of 9.59%.
September 2026
The global single-use bioprocessing connectors market size is accounted to hit around USD 6.34 billion by 2035 increasing from USD 1.74 billion in 2026, with a CAGR of 15.43%.
September 2026
The global precision genomic testing market size is valued at USD 20.55 billion in 2026 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
September 2026
The non-destructive testing (NDT) market size accounted for USD 24.59 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
September 2026
The global bacteriological testing market size was evaluated at USD 28.02 billion in 2026 and is predicted to hit around USD 54.35 billion by 2035, growing at a CAGR of 7.64%.
September 2026
The global generative AI in testing market size was evaluated at USD 73.19 million in 2026 and is predicted to hit around USD 439.81 million by 2035, growing at a CAGR of 22.05%.
September 2026
The global opioid use disorder market size is estimated to hit around USD 16.75 billion by 2035, increasing from USD 6.56 billion in 2026, with a CAGR of 11.00%.
September 2026
The global 5G testing market size is projected to surpass around USD 8.39 billion by 2034, increasing from USD 4.46 billion in 2026, with a solid CAGR of 8.22%.
September 2026
The global retinal vein occlusion market size is estimated to surpass around USD 5.78 billion by 2035 increasing from USD 3.22 billion in 2026, at a solid CAGR of 6.74%.
September 2026
The global automation testing market size was estimated at USD 48.88 billion in 2026 and is predicted to reach around USD 169.33 billion by 2034 with a CAGR of 16.90%.
September 2026
The biological safety testing market size was evaluated at USD 6.26 billion in 2026 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
September 2026
The bioprocess containers market size is valued at USD 4.88 billion in 2026 and is projected to surge around USD 36.63 billion by 2035 with a CAGR of 25.17%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global preterm birth and PROM testing market size is projected to hit around USD 3.45 billion by 2034 from USD 1.82 billion in 2026 with a CAGR of 8.22%.
September 2026
The global EMC testing market size was evaluated at USD 3.42 billion in 2026 and is predicted to hit around USD 6.62 billion by 2035, growing at a CAGR of 7.60%.
August 2026
Deepa Pandey a Healthcare Industry Expert, highlights that the bioanalytical testing services market has reached USD USD 6.23 billion in 2026 and is on track to reach USD 13.59 billion by 2035, advancing at a CAGR of 9.08%. Key bioanalytical testing services market companies shaping the market include PPD, Inc., ICON Plc, Charles River Laboratories International, Covance, Inc. while major growth segments By Test Type, By Molecules, By Application, By End User, By Region.
August 2026
The global healthcare CRM market size is expected to increase from USD 18.76 billion in 2025 to hit around USD 46.68 billion by 2035, with a CAGR of 9.54%.
February 2026
The global wireless testing market size was estimated at USD 27.14 billion in 2026 and is expected to hit around USD 54.84 billion by 2035, growing at a CAGR of 8.25% from 2026 to 2035.
August 2026
The global hemoglobin testing market size is calculated at USD 3.04 billion in 2025 and is projected to hit around USD 6.02 billion by 2035 with a CAGR of 7.07%.
August 2026
The global cannabis testing services market size is calculated at USD 2.68 billion in 2025 and is projected to hit around USD 7.22 billion by 2035 with a CAGR of 10.42%
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com